Pfiz­er to be­gin Ha­le­on ex­it in com­ing months — re­port

Pfiz­er will be­gin a “slow and me­thod­i­cal” ex­it of its 32% stake in Ha­le­on in the com­ing months, the com­pa­ny’s CFO told the Fi­nan­cial Times. 

The phar­ma gi­ant first an­nounced plans to sell its stake last June, rough­ly a month be­fore Ha­le­on de­buted on the Lon­don Stock Ex­change. The GSK spin­out was formed when Pfiz­er and GSK’s con­sumer health busi­ness­es merged in 2019, and holds pop­u­lar brands such as Sen­so­dyne tooth­paste, Ther­aflu and Advil.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER